The development of CRS can lead to various clinical symptoms and elevated concentration of biomarkers such as IL-1β, IL-2, IL-6, IL-7, IL-8, IL-10, IL-15, TNF-α, and IFN-γ [130]. This evidence concerns the gene IL15 and congenital rubella syndrome.